Cam Gallagher is the President & Chief Executive Officer of Alessa Therapeutics, a clinical-stage drug development company pioneering a localized drug delivery technology for the early treatment of prostate cancer. They are a serial biotechnology entrepreneur with over 30 years of experience in the biotechnology and pharmaceutical research industries as an executive, company founder, investor and board member. They currently serve on the board of directors for Opus Genetics (Nasdaq: IRD), SelectION, Immusoft and UC San Diego Health - Moores Cancer Center. Their prior leadership and board roles include co-founder, president and board member of Zentalis Pharmaceuticals (2014-2024); founding board member of VelosBio (2017-2020) and Zavante Therapeutics (2014-2018); and chief business officer and board member of RetroSense Therapeutics (2014-2016). They previously held various commercial sales and marketing positions at Dura Pharma, CV Therapeutics & Verus Pharma from 1992 to 2007.
This person is not in the org chart
This person is not in any teams
This person is not in any offices